All Updates

All Updates

icon
Filter
Partnerships
Massive Bio and Mika Health partner to expand psycho-oncology and clinical trial services across US and Europe
Clinical Trial Technology
Jun 2, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Clinical Trial Technology

Clinical Trial Technology

Jun 2, 2024

Massive Bio and Mika Health partner to expand psycho-oncology and clinical trial services across US and Europe

Partnerships

  • Massive Bio and Mika Health have partnered to enhance patient access to psycho-oncology services, biomarker testing, and clinical trials.

  • The partnership expects to expand patients’ access to Mika’s Digital Therapeutic for treating oncology-related fatigue, anxiety, and depression. Subsequently, patients using Digital Therapeutic can opt into Massive Bio’s clinical trial matching and biomarker testing service, while Mika’s Digital Therapy will be available to Massive Bio's cancer patient registry. By leveraging AI-powered data-driven insights, the companies aim to provide personalized psychotherapy, symptom management, side-effect interception, and educational resources to their patients.

  • Mika Health, also known as Fosanis, is a digital health company headquartered in Germany that specializes in providing AI-powered precision medicine solutions designed to support cancer patients through the treatment process. The company’s proprietary "Mika" app offers a range of services, including symptom tracking, personalized guidance, and practical advice on managing cancer-related physical and emotional challenges.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.